デフォルト表紙SALE
市場調査レポート
商品コード
1026956

分子診断の市場予測・競合動向・成長機会 (~2026年):製品&サービス・技術・用途・エンドユーザー・用途・地域別

Global Molecular Diagnostics Market, By Products and Services, By Technology, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026

出版日: | 発行: TechSci Research | ページ情報: 英文 111 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.08円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

分子診断の市場予測・競合動向・成長機会 (~2026年):製品&サービス・技術・用途・エンドユーザー・用途・地域別
出版日: 2021年09月01日
発行: TechSci Research
ページ情報: 英文 111 Pages
納期: 2-3営業日
担当者のコメント
2021年12月末までSingle User Licenseのディスカウントキャンペーンを実施中です。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の分子診断の市場規模は予測期間中2.98%のCAGRで推移し、2026年には804億5000万米ドルの規模に成長すると予測されています。

高齢者人口の増加、新型コロナウイルス感染症 (COVID-19) の世界的流行、ポイントオブケア (PoC) 診断への需要の増加、近年のファーマコゲノミクスの進展、遺伝子研究・遺伝子工学の分野における急速な技術革新などの要因が同市場の成長を推進する見通しです。

当レポートでは、世界の分子診断の市場を調査し、市場の定義と概要、COVID-19およびその他の市場影響因子の分析、顧客の声の分析、市場規模の推移・予測、製品&サービス・技術・用途・エンドユーザー・用途別の内訳、地域・主要国別の詳細分析、競合環境、市場シェア、主要企業のプロファイルなどをまとめています。

目次

第1章 製品の概要

第2章 調査手法

第3章 COVID-19の影響

第4章 エグゼクティブサマリー

第5章 顧客の声

第6章 世界市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 製品・サービス別
      • 試薬・キット
      • 機器
      • サービス
      • ソフトウェア
    • 技術別
      • ポリメラーゼ連鎖反応 (PCR)
      • シーケンシング
      • in-situハイブリダイゼーション
      • チップ・マイクロアレイ
      • 質量分析
      • その他
    • 用途別
      • 感染症検査
      • 癌検査
      • 遺伝子検査
      • 血液スクリーニング
      • その他
    • エンドユーザー別
      • 病院
      • 学術機関・リファレンスラボ
      • その他
    • 企業別
    • 地域別
  • 製品市場マップ

第7章 北米市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
    • 製品・サービス別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別

第8章 欧州市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
    • 製品・サービス別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別

第9章 アジア太平洋市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
    • 製品・サービス別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別

第10章 南米市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
    • 製品・サービス別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別

第11章 中東・アフリカ市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
    • 製品・サービス別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向

第14章 競合情勢

  • 競合の見通し
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories Ltd.
    • Danaher Corporation
    • Siemens Healthineers AG
    • Hologic Inc.(Gen Probe)
    • Illumina Inc.
    • Grifols S.A.
    • Bio-Rad Laboratories Inc.
    • Agilent Technologies Inc.
    • Thermo Fisher Scientific Inc.
    • Qiagen N.V.
    • Becton, Dickinson and Company Ltd.
    • Myriad Genetics Inc.
    • Johnson & Johnson Services, Inc.
    • bioMerieux SA

第15章 戦略的推奨事項

第16章 当社について&免責事項

図表

List of Figures

  • Figure 1: Global Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 2: Global Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 3: Global Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 4: Global Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 5: Global Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 6: Global Molecular Diagnostics Market Share, By Company, By Value, 2020
  • Figure 7: Global Molecular Diagnostics Market Share, By Region, By Value, 2016-2026F
  • Figure 8: Global Molecular Diagnostics Product Market Map, By Value, 2016-2026F
  • Figure 9: North America Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 10: North America Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 11: North America Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 12: North America Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 13: North America Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 14: North America Molecular Diagnostics Market Share, By Country, By Value, 2020
  • Figure 15: United States Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 16: United States Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 17: United States Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 18: United States Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 19: United States Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 20: Canada Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 21: Canada Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 22: Canada Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 23: Canada Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 24: Canada Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 25: Mexico Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 26: Mexico Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 27: Mexico Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 28: Mexico Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 29: Mexico Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 30: Europe Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 31: Europe Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 32: Europe Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 33: Europe Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 34: Europe Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 35: Europe Molecular Diagnostics Market Share, By Country, By Value, 2020
  • Figure 36: France Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 37: France Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 38: France Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 39: France Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 40: France Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 41: United Kingdom Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 42: United Kingdom Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 43: United Kingdom Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 44: United Kingdom Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 45: United Kingdom Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 46: Germany Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 47: Germany Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 48: Germany Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 49: Germany Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 50: Germany Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 51: Italy Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 52: Italy Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 53: Italy Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 54: Italy Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 55: Italy Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 56: Spain Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 57: Spain Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 58: Spain Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 59: Spain Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 60: Spain Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 61: Asia-Pacific Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 62: Asia-Pacific Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 63: Asia-Pacific Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 64: Asia-Pacific Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 65: Asia-Pacific Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 66: Asia-Pacific Molecular Diagnostics Market Share, By Country, By Value, 2020
  • Figure 67: China Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 68: China Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 69: China Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 70: China Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 71: China Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 72: Japan Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 73: Japan Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 74: Japan Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 75: Japan Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 76: Japan Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 77: India Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 78: India Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 79: India Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 80: India Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 81: India Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 82: Australia Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 83: Australia Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 84: Australia Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 85: Australia Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 86: Australia Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 87: South Korea Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 88: South Korea Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 89: South Korea Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 90: South Korea Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 91: South Korea Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 92: Singapore Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 93: Singapore Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 94: Singapore Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 95: Singapore Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 96: Singapore Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 97: South America Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 98: South America Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 99: South America Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 100: South America Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 101: South America Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 102: South America Molecular Diagnostics Market Share, By Country, By Value, 2020
  • Figure 103: Brazil Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 104: Brazil Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 105: Brazil Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 106: Brazil Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 107: Brazil Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 108: Argentina Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 109: Argentina Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 110: Argentina Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 111: Argentina Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 112: Argentina Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 113: Colombia Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 114: Colombia Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 115: Colombia Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 116: Colombia Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 117: Colombia Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 118: Middle East and Africa Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 119: Middle East and Africa Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 120: Middle East and Africa Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 121: Middle East and Africa Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 122: Middle East and Africa Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 123: Middle East and Africa Molecular Diagnostics Market Share, By Country, By Value, 2020
  • Figure 124: South Africa Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 125: South Africa Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 126: South Africa Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 127: South Africa Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 128: South Africa Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 129: Saudi Arabia Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 130: Saudi Arabia Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 131: Saudi Arabia Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 132: Saudi Arabia Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 133: Saudi Arabia Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
  • Figure 134: UAE Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 135: UAE Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
  • Figure 136: UAE Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
  • Figure 137: UAE Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
  • Figure 138: UAE Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
目次
Product Code: 7463

Global molecular diagnostics market is projected to reach USD80.45 billion by 2026, growing at CAGR of 2.98% through 2026, owing to increasing geriatric population and rising cases of infectious diseases including COVID-19. The market growth can be attributed to large outbreaks of bacterial and viral epidemics in the world, increasing demand for Point-of-Care (PoC) diagnostics, recent advancements in pharmacogenomics and rapidly evolving technologies in the field of genetic research and engineering are expected to drive the growth of the market in the coming five years. Moreover, rising instances of infectious diseases in the world are also driving the molecular diagnostic department to find the efficient and effective treatment and therapeutics for the diseases thereby sustaining the growth of the market in the next five years. Furthermore, the governments are actively aiding the research and development sector in the molecular diagnostics financially which can be attributed as the major factor for the market growth.

Rising instances of unpredictable pathogens and changing lifestyles has given birth to diseases that were unknown. Recent example of COVID-19 virus has driven the governments, as well as the consumers and market players towards the need of research and development for the treatment and therapeutic plans for the infectious, and chronic diseases. Genetic mutations due to environmental factors, radiation and various other factors are increasing, causing deformed birth of human population, thereby driving the growth of the market.

The global molecular diagnostics market is segmented into products & services, technology, application, end user, regional distribution, and competitional landscape. Based on technology the market is further bifurcated into Polymerase Chain Reaction (PCR), sequencing, in-situ hybridization, chips and microarrays, mass spectrometry and others. Polymerase chain reaction (PCR) is anticipated to hold the largest market share in the next five years on the account of its use in the detection of infectious microorganisms such as viruses and bacteria. Polymerase chain reaction is a method of multiplication of the genetic material to reach billions of the copies. The method allows the scientists to study the DNA, RNA, or other genetic material sample after the specific gene or segment of the genetic material is amplified. The method uses the ability of the genetic material to multiply and rapidly increase the process in order to obtain a large amount in much smaller span of time.

Major companies operating in the global molecular diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories Ltd., Danaher Corporation, Siemens Healthineers AG, Hologic Inc. (Gen Probe), Illumina Inc., Grifols S.A., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Becton, Dickinson and Company Ltd., Myriad Genetics Inc., Johnson & Johnson Services, Inc., bioMerieux SA, among others.

Years considered for this report:

Historical Years: 2016 - 2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022 - 2026

Objective of the Study:

  • To analyze the historical growth in the market size of the global molecular diagnostics market from 2016 to 2020.
  • To estimate and forecast the market size of the global molecular diagnostics market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast the global molecular diagnostics market based on products & services, technology, application, end user, regional distribution, and competitional landscape.
  • To identify dominant region or segment in the global molecular diagnostics market.
  • To identify drivers and challenges for the global molecular diagnostics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global molecular diagnostics market.
  • To identify and analyze the profile of leading players operating in the global molecular diagnostics market.
  • To identify key sustainable strategies adopted by market players in the global molecular diagnostics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers globally. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global molecular diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers, end users and other stakeholders
  • Distributors and suppliers of kits, reagents and assays and other stakeholders
  • Organizations, forums and alliances related to molecular diagnostics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as vendors, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global molecular diagnostics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Global Molecular Diagnostics Market, By Products and Services:

Reagents and Kits

Instruments

Services and Software

  • Global Molecular Diagnostics Market, By Technology:

Polymerase Chain Reaction (PCR)

Sequencing

In-situ hybridization

Chips and microarrays

Mass spectrometry

Others

  • Global Molecular Diagnostics Market, By Application:

Infectious disease

Oncology Testing

Genetic Testing

Blood Screening

Others

  • Global Molecular Diagnostics Market, By End User:

Hospitals

Academic & Reference Laboratories

Others

  • Global Molecular Diagnostics Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • France
  • United Kingdom
  • Germany
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global molecular diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Molecular Diagnostics Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Factors Driving the Molecular Diagnostics Market
  • 5.2. Brand Awareness
  • 5.3. Customer Satisfaction Analysis

6. Global Molecular Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Products and Services (Reagents and Kits, Instruments, Services and Software)
    • 6.2.2. By Technology (Polymerase Chain Reaction (PCR), Sequencing, In-situ hybridization, Chips and microarrays, Mass spectrometry, Others)
    • 6.2.3. By Application (Infectious disease, Oncology testing, Genetic testing, Blood Screening, Others)
    • 6.2.4. By End User (Hospitals, Academic & Reference Laboratories, Others)
    • 6.2.5. By Company (2020)
    • 6.2.6. By Region
  • 6.3. Product Market Map

7. North America Molecular Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Products and Services
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Molecular Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Products and Services
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Canada Molecular Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Products and Services
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Mexico Molecular Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Products and Services
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. Europe Molecular Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Products and Services
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Molecular Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Products and Services
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. United Kingdom Molecular Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Products and Services
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Germany Molecular Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Products and Services
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Molecular Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Products and Services
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Molecular Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Products and Services
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Asia-Pacific Molecular Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Products and Services
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Molecular Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Products and Services
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Japan Molecular Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Products and Services
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. India Molecular Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Products and Services
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
    • 9.3.4. Australia Molecular Diagnostics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Products and Services
        • 9.3.4.2.2. By Technology
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End User
    • 9.3.5. South Korea Molecular Diagnostics Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Products and Services
        • 9.3.5.2.2. By Technology
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By End User
    • 9.3.6. Singapore Molecular Diagnostics Market Outlook
      • 9.3.6.1. Market Size & Forecast
        • 9.3.6.1.1. By Value
      • 9.3.6.2. Market Share & Forecast
        • 9.3.6.2.1. By Products and Services
        • 9.3.6.2.2. By Technology
        • 9.3.6.2.3. By Application
        • 9.3.6.2.4. By End User

10. South America Molecular Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Products and Services
    • 10.2.2. By Technology
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Molecular Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Products and Services
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Molecular Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Products and Services
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Molecular Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Products and Services
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Molecular Diagnostics Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Products and Services
    • 11.2.2. By Technology
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Molecular Diagnostics Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Products and Services
        • 11.3.1.2.2. By Technology
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Molecular Diagnostics Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Products and Services
        • 11.3.2.2.2. By Technology
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Molecular Diagnostics Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Products and Services
        • 11.3.3.2.2. By Technology
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled
    • 14.2.1. F. Hoffmann-La Roche Ltd.
    • 14.2.2. Abbott Laboratories Ltd.
    • 14.2.3. Danaher Corporation
    • 14.2.4. Siemens Healthineers AG
    • 14.2.5. Hologic Inc. (Gen Probe)
    • 14.2.6. Illumina Inc.
    • 14.2.7. Grifols S.A.
    • 14.2.8. Bio-Rad Laboratories Inc.
    • 14.2.9. Agilent Technologies Inc.
    • 14.2.10. Thermo Fisher Scientific Inc.
    • 14.2.11. Qiagen N.V.
    • 14.2.12. Becton, Dickinson and Company Ltd.
    • 14.2.13. Myriad Genetics Inc.
    • 14.2.14. Johnson & Johnson Services, Inc.
    • 14.2.15. bioMerieux SA

15. Strategic Recommendations

16. About Us & Disclaimer